1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Patient characteristics
Characteristic Sex (female/male ratio) 8:17 Age on follow-up MRI (range) (yr) 66 (39–86) MRI examinations (No.) (%)a 1 Time 19 (76) 2 Times 3 (12) 3 Times 2 (8) 4 Times 1 (4) Follow-up period (range) (mo) 33 ± 35 (0.5–142) Symptom on admission (No.) (%) None 15 (43) Pure motor 16 (46) Hemiplegia 2 (6) Hemianopsia 2 (6) Vascular risk factors (No.) (%) DM 8 (32) HL 3 (12) HT 12 (48) Smoking 6 (24)
Note:—DM indicates diabetes mellitus; HL, hyperlipidemia; HT, hypertension.
↵a Number of initial MRI examination per patients.